Inhaler Cyclone Chamber for Particle Deagglomeration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional inhalers for delivering dry powder medicaments to the lungs suffer from variability in particle size distribution, leading to inconsistent and inefficient delivery, which is unacceptable for systemic pulmonary drugs, resulting in unpredictable therapeutic effects and drug wastage.
Innovation Solution
The inhaler design incorporates a cyclone chamber with a tangential bypass air inlet, creating a vortex that interacts with the drug-laden air flow, causing it to follow a helical path and increasing shear forces, which deagglomerates particles and enhances the fine particle fraction, ensuring consistent and efficient delivery of medicaments to the lungs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional inhaler design is used, then device simplicity is maintained, but particle size distribution varies significantly leading to inconsistent drug delivery
Solution Approach 1:
The inhaler is divided into functionally distinct segments: a bypass chamber for generating vortex flow and a main drug delivery chamber. This segmentation allows the vortex-generating bypass inlet to be integrated without significantly increasing overall device complexity while achieving consistent particle size distribution through the vortex-induced shear forces.
Solution Approach 2:
The bypass air inlet is merged with the main drug delivery pathway, creating an integrated vortex chamber that combines airflow generation and drug particle conditioning in a single structural unit. This merging achieves improved particle size consistency without adding separate complex components.
2Manufacturing precision
If particle size is reduced to increase fine particle fraction, then deep lung delivery is improved, but particles may be expelled with exhaled airflow
Solution Approach 1:
The vortex-induced shear forces dynamically adjust particle aerodynamic diameter during inhalation, optimizing particles to fall within the 1-3 micron range ideal for deep lung penetration while maintaining sufficient mass for reliable absorption. This dynamic parameter control prevents both过大 particles from trapping and过小 particles from expulsion.
3Manufacturing precision
If cyclone chamber is added to deagglomerate particles, then fine particle fraction increases, but device complexity increases
Solution Approach 1:
The bypass chamber serves multiple functions: generating vortex flow for particle deagglomeration, conditioning airflow before drug delivery, and integrating structural support. This multi-functionality achieves enhanced fine particle fraction without the need for additional dedicated deagglomeration components.
4Manufacturing precision
If bypass air inlet is positioned to create vortex, then particle deagglomeration is enhanced, but airflow pattern complexity increases
Solution Approach 1:
The bypass air inlet is positioned and shaped to generate smooth curved vortex flow patterns within the chamber. This curved airflow design efficiently deagglomerates particles through centrifugal and shear forces while maintaining relatively simple airflow paths that do not require complex internal structures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This design significantly increases the fine particle fraction by up to 200%, ensuring a more predictable and consistent therapeutic effect while minimizing drug wastage and potentially harmful side effects, by effectively deagglomerating particles and optimizing particle size for deep lung absorption.
Implementation Method 1
a bypass air inlet for the flow of clean air into the chamber, so that air entering the chamber through the inlet substantially tangential to the wall of the chamber forms a cyclone in the chamber
Implementation Method 2
creating a vortex that interacts with the drug-laden air flow, causing it to follow a helical path
Implementation Method 3
increasing shear forces, which deagglomerates particles and enhances the fine particle fraction
Data Source
Figure 1~2
Figure 3~4
AI summary
An inhaler for producing an inhalable aerosol of powdered medicament is disclosed. The inhaler includes an aerosolising device having a chamber of substantially circular cross-section, inlet and outlet ports at opposite ends of the chamber for the flow of drug laden air through the chamber between said ports and, a bypass air inlet for the flow of clean air into the chamber. The bypass air inlet is configured so that air entering the chamber through said inlet forms a cyclone in the chamber that interacts with the drug laden air flowing between the inlet and outlet ports.